Nureca Limited has informed the Exchange regarding Appointment of Ms Charu Singh as Independent Director of the company w.e.f. October 21, 2025 for a period of 5 years .
NURECA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nureca Limited's board, at its May 5, 2025 meeting, approved audited standalone and consolidated financial results for Q4 and FY ending March 31, 2025, with an unmodified auditor opinion from B S R & Co. LLP. The board appointed M/s Singhi & Co as new statutory auditors for five years (from 9th AGM in 2025 to 14th AGM in 2030), replacing B S R & Co. LLP at the end of their term, and also appointed MGSG and Associates as internal auditors for FY 2025-26 and A. Arora & Company as secretarial auditors for five years. It in-principally approved merging wholly owned subsidiary Nureca Technologies Private Limited (FY25 revenue Rs 228.14 million, net worth Rs 53.94 million) into Nureca Limited (FY25 standalone revenue Rs 1,146.40 million, net worth Rs 1,917.38 million) to simplify the group structure, with no change in shareholding pattern since no new shares will be issued. The board re-appointed three independent directors (Ms Charu Singh, Ms Ruchita Agarwal, Mr Vijay Kumar Sharma) and Whole-Time Director Mr Rajinder Sharma for second terms of five years, and approved the re-appointment of Mr Saurabh Goyal, who retires by rotation. The 9th AGM is scheduled for June 16, 2025 via video conferencing.
This is a routine housekeeping board outcome with no negative surprises — clean audit, planned auditor rotation, internal simplification via merger of a wholly owned subsidiary, and continuity of the board. Shareholders are unlikely to see a meaningful stock reaction, though the merger of the subsidiary may streamline costs over time.